{"url":"https://lda.senate.gov/api/v1/filings/e05bb997-e538-4a70-89ad-98b90af8f6ca/","filing_uuid":"e05bb997-e538-4a70-89ad-98b90af8f6ca","filing_type":"4A","filing_type_display":"4th Quarter - Amendment","filing_year":2022,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/e05bb997-e538-4a70-89ad-98b90af8f6ca/print/","filing_document_content_type":"text/html","income":null,"expenses":"100000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Kelli Arthur Hykes","dt_posted":"2023-08-03T14:57:53-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"101 S Ellsworth Ave #350","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"San Mateo","registrant_state":"CA","registrant_zip":"94401","registrant":{"id":401106164,"url":"https://lda.senate.gov/api/v1/registrants/401106164/","house_registrant_id":null,"name":"HELIX, INC.","description":"Genomics","address_1":"101 S Ellsworth Ave #350","address_2":null,"address_3":null,"address_4":null,"city":"San Mateo","state":"CA","state_display":"California","zip":"94401","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KELLI ARTHUR HYKES","contact_telephone":"+1 614-282-3116","dt_updated":"2025-06-15T16:43:12.631879-04:00"},"client":{"id":211349,"url":"https://lda.senate.gov/api/v1/clients/211349/","client_id":12,"name":"HELIX, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-05-17"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Human and Viral Genomic research, testing,funding and insurance coverage, pandemic preparedness, viral surveillance, Lab Developed Tests H791 and S236 COVID-19 Variants Data Tracking (viral sequencing and analytic supports) H6584 Clinical Trial Diversity H 7667 Rx Drug and Device User Fee Programs (regulation of Lab Developed Tests) H 4128 VALID Act (regulation of Lab Developed Tests) H 2471 Omnibus (PREVENT Pandemics Act, funding for Advanced Molecular Detection, and VALID Act) S2022 Whole Genome Sequencing Clinic (Whole Exome sequencing)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142741,"prefix":"mrs","prefix_display":"MRS.","first_name":"KELLI","nickname":null,"middle_name":"ARTHUR","last_name":"HYKES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"viral and human genomic research, testing,funding and insurance coverage, COVID-19 testing and research, Lab Developed Tests H791 and S236 COVID-19 Variants Data Tracking (viral sequencing and analytic supports) H6584 Clinical Trial Diversity H 7667 Rx Drug and Device User Fee Programs (regulation of Lab Developed Tests) H 4128 VALID Act (regulation of Lab Developed Tests) H 2471 Omnibus (PREVENT Pandemics Act, funding for Advanced Molecular Detection, and VALID Act) S2022 Whole Genome Sequencing Clinic (Whole Exome sequencing)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142741,"prefix":"mrs","prefix_display":"MRS.","first_name":"KELLI","nickname":null,"middle_name":"ARTHUR","last_name":"HYKES","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Covid Supplemental for surveillance and testing H2471 Omnibus (Funding for viral sequencing and surveillance, Advanced Molecular Detection, Public Health Infrastructure)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142741,"prefix":"mrs","prefix_display":"MRS.","first_name":"KELLI","nickname":null,"middle_name":"ARTHUR","last_name":"HYKES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}